Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Canada
COVID-19
NITAG documentation
2022
Clear all
Type of publications
NITAG documentation
(13)
Systematic reviews (SYSVAC)
(2)
Topics
Recommendation
(13)
Regions
Americas
(13)
Countries
Canada
(13)
Argentina
(2)
Australia
(11)
Belgium
(5)
Burkina Faso
(1)
Chile
(4)
France
(9)
Germany
(2)
Ireland
(4)
Netherlands
(1)
Niger
(1)
Spain
(1)
Uganda
(3)
United Kingdom
(4)
United States of America
(11)
Uruguay
(1)
Diseases
COVID-19
(13)
Influenza
(1)
Mpox // Monkeypox
(2)
Publication date
2022
(13)
2024
(1)
2023
(5)
2021
(15)
2020
(4)
Target population
Adolescents
(1)
Children
(1)
Pregnant women
(1)
Available to download in languages
English (EN)
(13)
13 results found
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2022
∙
NACI
Updated guidance on COVID-19 vaccine booster doses in Canada
2022
∙
NACI
Recommendations on the use of bivalent Omicroncontaining mRNA COVID-19 vaccines
2022
∙
Public Health Agency of Canada
Updated guidance on COVID-19 vaccines for individuals who are pregnant or breastfeeding
2022
∙
NACI
Initial guidance on a second booster dose of COVID-19 vaccines in Canada
2022
∙
NACI
Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada
2022
∙
NACI
NACI Recommendations on the use of Medicago COVID-19 vaccine (Covifenz)
2022
∙
NACI
NACI Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age
2022
∙
NACI
NACI Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine
2022
∙
NACI
Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register